The global Veterinary Dermatology Drugs Market size was estimated at USD 3,265.7 Mn in 2021, growing at a CAGR of 5.8% during the forecast period 2021-2027. Global veterinary dermatology drugs market is projected to expand at robust growth rate over the forecast period. Veterinary profession has experienced a dramatic shift from the past few decades. Several demographic and socioeconomic factors have contributed to drastic changes, including livestock, food production, social attitudes, urbanization, increased adoption of companion animals are expected fuel the veterinary dermatology drugs market over the forecast period. Atopic dermatitis is the common cause of itching in companion animals. Atopy is genetically determined predisposition to become allergic to airborne pollens such as weeds, grass, trees, house dust, and molds. In companion animals dogs, cats atopic dermatitis is most common cause of chewing, biting, rubbing as well as chronic skin and ear infections. Surge in the prevalence of chronic skin disorders anticipated to boost the market revenue size. Increasing demand for farm animal and poultry sector is expected to boost the veterinary dermatology drugs market. Rising awareness regarding various dermatological disorders and treatment methods, favorable government initiatives in order to increase farm animal production are expected to create demand for the market in future. Animals are susceptible to numerous chronic skin disorders. Some skin tumours can be treated using medical therapy or cryotherapy. Skin disorders can be occurring by various agents such as allergens, burns, external irritants, trauma (Viral, bacterial, fungal, other parasitic). Evolution of chronic skin diseases and increased mergers & acquisitions to offer better products are able to offer novel products to the market. Rising awareness among the pet lovers and increased health checkups are expected to create lucrative opportunities in the future.